Acute management of seizures in the syndromes of idiopathic generalized epilepsies

Epilepsia

Volumn 44, Issue SUPPL. 2, 2003, Pages 22-26

  Wheless, James W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Absence; Generalized tonic clonic; Genetic; Idiopathic generalized epilepsy; Juvenile myoclonic epilepsy; Myoclonic; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; GABAPENTIN; LORAZEPAM; MIDAZOLAM; TIAGABINE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONSCIOUSNESS; CONVALESCENCE; CONVULSION; EPILEPSY; EPILEPTIC STATE; FEMALE; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HUMAN; MALE; MYOCLONUS; MYOCLONUS SEIZURE; PRIORITY JOURNAL; SEIZURE; SYNDROME DELINEATION; TONIC SEIZURE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTICONVULSANTS; CLONAZEPAM; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; EPILEPSIES, MYOCLONIC; EPILEPSY, ABSENCE; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; HUMANS; INFUSIONS, INTRAVENOUS; LORAZEPAM; PRACTICE GUIDELINES; STATUS EPILEPTICUS; SYNDROME; VALPROIC ACID;

EID: 0038523811     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.44.s.2.5.x     Document Type: Conference Paper

References (23)

1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:498-501.
2. Badhwar A, Siren H, Andermann E, Andermann F. Myoclonic status epilepticus: video presentation. Mov Disord 2002;17:40911.
3. Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia 1995;36:S13-26.
4. Wheless J, Venkataraman V. Safety of high intravenous valproate loading doses in epilepsy patients. J Epilepsy 1998;11:319-24.
5. Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus [Clinical Note]. Neurology 2000;54:1201.
6. Andermann F, Robb JP. Absence status: a reappraisal following review of thirty-eight patients. Epilepsia 1972;13:177-87.
7. Agathonikou A, Panayiotopoulos CP, Giannakodimos S, Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia 1998;39:1265-76.
8. Baykan B, Gokyigit A, Gurses C, Eraksoy M. Recurrent absence status epilepticus: clinical and EEG characteristics. Seizure 2002;11:310-9.
9. Dziewas R, Kellinghaus C, Ludemann P. Nonconvulsion status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies. Seizure 2002;11:335-9.
10. Berkovic SF, Andermann F, Guberman A, Hipola D, Bladin PF. Valproate prevents the recurrence of absence status. Neurology 1989;39:1294-7.
11. Walsh GO, Delgado-Escueta AV. Status epilepticus. Neuro Clin 1993;11:835-56.
12. Naritoku DK, Mueed S. Intravenous loading of valproate for epilepsy. Clin Neuropharmacol 1999;22:102-6.
13. Karceski S, Morrell M, Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav 2001;2:A1-50.
14. Rey E. Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes. Clin Pharmacokinet 1999;36:409-24.
15. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39:5-17.
16. Ostrovskiy D, Spanaki MV, Morris GL III. Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 2002;43:773-4.
17. Skodda S, Kramer I, Spittler JF, Gehlen W. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol 2001;248:109-12.
18. Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998;39:671-4.
19. Balslev T, Uldall P, Buchholt J. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients. Eur J Paediatr Neurol 2000;4:169-70.
20. Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000;41:887-94.
21. Guerrini R, Belmonte A, Parmeggiani L, Perucca E. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 1999;21:420-4.
22. Dulac O, Plouin P, Shewmon A. Myoclonus and epilepsy in childhood: 1996 Royaumont meeting. Epilepsy Res 1998;30:91-106.
23. Asconape J, Diedrich A, Della Badia J. Myoclonus associated with the use of gabapentin. Epilepsia 2000;41:479-81.